| Product NDC: | 55390-101 |
| Proprietary Name: | Terbutaline Sulfate |
| Non Proprietary Name: | Terbutaline Sulfate |
| Active Ingredient(s): | 1 mg/mL & nbsp; Terbutaline Sulfate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-101 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076770 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040428 |
| Package NDC: | 55390-101-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-101-10) > 1 mL in 1 VIAL |
| NDC Code | 55390-101-10 |
| Proprietary Name | Terbutaline Sulfate |
| Package Description | 10 VIAL in 1 BOX (55390-101-10) > 1 mL in 1 VIAL |
| Product NDC | 55390-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Terbutaline Sulfate |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20040428 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | TERBUTALINE SULFATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |